Study Details

Back to Search Results

A prospective non-interventional study in overactive bladder (OAB) patients prescribed Betmiga® as part of routine clinical practice

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT02320773

Astellas Study ID

The unique identification code given by the study sponsor.

178-MA-1002

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Urge to Urinate, Overactive Bladder Disease, Bladder Disease

Phase

N/A

Age

18 years - N/A

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific interventions/treatment.

Observational

Trial Dates

Nov 2014 - Jul 2016

Masking

Not Available

Enrollment number

863

Non-Interventional Study Assessing Quality of Life, Treatment Satisfaction, Resource Utilisation, and Persistence with Treatment in Overactive Bladder (OAB) Patients Prescribed Betmiga® - A Multicenter Non-interventional Post Authorisation Study (PAS)

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A prospective non-interventional study in overactive bladder (OAB) patients prescribed Betmiga® as part of routine clinical practice? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Site ES34010 Policlínico de Vigo, S.A.-POVISA

Vigo, Spain, 36211

Site GB44005 Bradford Royal Infirmary

Bradford, United Kingdom, BD9 6RJ

Site GR30003 University Hospital of Patras

Patras, Greece, 26504

Site GB44003 Derriford Hospital

Derriford, United Kingdom, PL6 8DH

Site ES34009 Hospital Comarcal Santiago Apostol

Burgos, Spain, 09200

Site DK45004 Regionshospitalet Herning

Herning, Denmark, 7440

Site GB44017 Sunderland Royal University Hospital

Sunderland, United Kingdom, SR4 7TP

Site IE35303 Kerry General Hospital

Kerry, Ireland

Site CZ42006 Hospital Kyjov

Kyjov, Czech Republic

Site SE46002 Urologkliniken Carlanderska

Göteborg, Sweden, 412 55

Site GB44016 Addenbrookes Hospital

Cambridge, United Kingdom, CB2 0QQ

Site GR30008 University Hospital of Ioannina

Ioannina, Greece, 45445

Site SK42106 UROCENTRUM LEVICE, s.r.o.

LEVICE, Slovakia, 934 01,

Site ES34012 H. de Mendaro

Mendaro, Spain, 20850

Site GB44013 Hinchingbrooke Hospital

Huntingdon, United Kingdom, PE29 6NT

Site GB44008 Croydon University Hospital

Croydon, United Kingdom, CR7 7YE

Site IE35302 Coombe Hospital

Dublin 8, Ireland

Site SK42102 UROAMB, s.r.o.

LIPTOVSKÝ MIKULÁŠ, Slovakia, 03101

Site GR30001 General Hospital of Athens "Alexandra"

Athens, Greece, 11528

Site CZ42004 Krajská nemocnice Tomáše Bati

Zlín, Czech Republic

Site ES34019 Hospital Universitario Lucus Augusti

Lugo, Spain, 27003

Site CZ42002 Fakultni nemocnice Kralovske Vinohrady

Praha 10, Czech Republic

Site ES34021 H. de Donostia

San Sebastian, Spain, 20014

Site CZ42008 Oblastni nemocnice Pribram

Příbram, Czech Republic

Site ES34017 Hospital de Mollet

Barcelona, Spain

Site GB44018 Salisbury District Hospital

Salisbury, United Kingdom, SP2 8BJ

Site GR30002 University Hospital of Crete

Heraklion, Greece, 71110

Site GR30005 University Hospital of Larissa

Larisa, Greece, 41110

Site SK42104 Urologicka ambulancia, Miramed, sro

RIMAVSKÁ SOBOTA, Slovakia, 979 01

Site GB44015 University Hospital Coventry

Coventry, United Kingdom, CV2 2DX

Site CZ42007 MEDICON a.s.

Praha 4, Czech Republic

Site GR30011 General Hospital of Heraklion 'Venizelio-Pananio'

Heraklion, Greece, 71409

Site ES34011 Hospital del Rio Hortega

Valladolid, Spain, 47011

Site DK45003 Sygehus Vendsyssel, Frederikshavn

Frederikshavn, Denmark, 9900

Site SK42101 Univerzitná nemocnica Bratislava - Kramáre

BRATISLAVA 3, Slovakia, 833 05

Site CZ42003 Fakultni nemocnice Brno-Bohunice

Brno, Czech Republic

Site GB44004 Southern General Hospital

Glasgow, United Kingdom, G51 4TF

Site GB44010 The Freeman Hospital

Newcastle upon Tyne, United Kingdom, NE7 7DN

Site SK42105 ProCare Ziar nad Hronom

ŽIAR NAD HRONOM, Slovakia, 965 63

Site GB44001 Medway Hospital

Gillingham, United Kingdom, ME5 7NY

Site GB44009 St. Richards Hospital

Chichester, United Kingdom, PO19 6SE

Site ES34007 Hospital Universitario Vall D'Hebron

Barcelona, Spain, 08035

Site GR30009 PGH Laiko

Athens, Greece, 11527

Site GB44011 Royal Blackburn Hospital

Burnley, United Kingdom, BB10 2PQ

Site GB44019 Northern Devon Healthcare

Devon, United Kingdom, EX31 4JB

Site GR30006 Papageorgiou General Hospital

Thessaloniki, Greece, 56403

Site GB44014 The Queen Elizabeth Hospital King's Lynn NHS Trust

Norfolk, United Kingdom, PE30 4ET

Site GB44006 New Cross Hospital

Wolverhampton, United Kingdom, WV10 OQP

Site SK42103 CMFF, sro

VRANOV NAD TOPĽOU, Slovakia, 093 01

Site GB44007 Northampton General Hospital

Cliftonville, United Kingdom, NN1 5BD

Site GR30012 Papageorgiou General Hospital of Thessaloniki

Thessaloniki, Greece, 56403

Site ES34015 Centro Médico Teknon

Barcelona, Spain, 08022

Site IE35304 Midland Regional Hospital

Mullingar, Ireland

Site ES34005 Corporació Sanitaria Parc Taulí

Sabadell, Spain, 08208

Site ES34020 Hospital Universitario Basurto

Bilbao, Spain, 48013

Site CZ42009 UROMEDA s. r. o.

Brno, Czech Republic, 615 00

Site GR30013 University Hospital of Ioannina

Ioannina, Greece, 45500

Site SK42107 Private Urological Care Center

Trenčín, Slovakia

Site GR30007 Sismanoglio General Hospital

Athens, Greece, 151 26

Site GB44002 The Royal Berkshire Hospital

Reading, United Kingdom, RG1 5AN

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo